Johnson & Johnson’s Latest Recall, Kodiak’s Buy Pays Off, and 3 More Hot Stocks

Johnson & Johnson (NYSE:JNJ): The pharmaceutical and health care giant is is recalling 5,000 vials of its Risperdal Consta schizophrenia treatment after tests found that one lot of the drug was contaminated with alternaria alternata, a common mold. The recall is preemptive, as no reports of patient complications have surfaced. Just last week, Johnson & Johnson recalled 200,000 bottles of its Motrin Infants Drops formula due to a risk that they contained tiny plastic particles.

JNJ 20130912